Fundz

Ada Rx Pharmaceuticals reported raising $46 Million in an initial SEC Form D filing, from an offering of $46 Million

PUBLIC · ADRXJan 26, 2023

Amount Raised

$46 Million

$46 Million sold, per SEC Form D (first sale Jan 26, 2023)

Round Type

Venture

San DiegoBiotechnologyHealthcareHealth CareTherapeutics

Quick answer

ADARx Pharmaceuticals, Inc. raised $46 Million in a funding round, dated January 26, 2023. ADARx Pharmaceuticals, Inc. is based in San Diego, California, United States.

How much did ADARx Pharmaceuticals, Inc. raise?
ADARx Pharmaceuticals, Inc. raised $46 Million in a funding round on January 26, 2023.
What does ADARx Pharmaceuticals, Inc. do?
ADARx Pharmaceuticals is a newly launched next-wave genetic medicine company focusing on oligonucleotide therapeutics for inhibition, degradation and base editing of mRNA transcripts.
Where is ADARx Pharmaceuticals, Inc. based and how big is it?
ADARx Pharmaceuticals, Inc. is based in San Diego, California, United States. Fundz records about 103 employees.
Who are the decision-makers at ADARx Pharmaceuticals, Inc?
Fundz holds 1 contact at ADARx Pharmaceuticals, Inc., including the Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Therapeutics around the same time

Companies in the same sectors as ADARx Pharmaceuticals, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • QurAlis raised $88M (Series B) on March 9, 2023.
  • Tessera Defense & Homeland Security Inc. raised $1.5M (Seed) on February 27, 2023.
  • Azora Therapeutics, Inc. (DE) raised $62K (Pre-Seed) on February 23, 2023.
  • Inhibikase Therapeutics raised $4.2M (Seed) on January 27, 2023.
  • Madrigal Pharmaceuticals raised $300M (Funding Round) on December 21, 2022.
  • QurAlis raised $60M on December 20, 2022.

Who to call at ADARx Pharmaceuticals, Inc., and when

A new round usually means ADARx Pharmaceuticals, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day ADARx Pharmaceuticals, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ADARx Pharmaceuticals, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ADARx Pharmaceuticals, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ADARx Pharmaceuticals, Inc.

Location

5871 OBERLIN DRIVE, SUITE 200

San Diego, California, United States

About

ADARx Pharmaceuticals is a newly launched next-wave genetic medicine company focusing on oligonucleotide therapeutics for inhibition, degradation and base editing of mRNA transcripts. With RNA as the target of our drug discovery, we are capable of working on a wide range of diseases and are currently focusing on genetic, cardiometabolic, and central nervous system (CNS) diseases. We are driven by our mission to turn cutting-edge science into life-saving therapeutics and our desire to provide hope for patients with intractable disease. We are well-financed with backup from a group of renowned VC funds, and our brand-new laboratory is located in San Diego, California.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ADARx Pharmaceuticals, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts Christopher C., Director hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for ADARx Pharmaceuticals, Inc.'s next move

See what Strategic adds

ADARx Pharmaceuticals, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.